Table 2.
DBL numbering [59] | OXA-10 | OXA-23 | OXA-48 |
---|---|---|---|
69 | Ala66 | Ala78 | Ala69 |
70 | Ser67 | Ser79 | Ser70 |
73 | Lys70CX | Lys82CX | Lys73CX |
76 | Asn73 | Asn85 | Asn76 |
102 | : Met99 | : Phe110 | : Ile102 |
105 | Trp102 | Trp113 | Trp105 |
118 | Ser115 | Ser126 | Ser118 |
120 | Val117 | Val128 | Val120 |
123 | : Phe120 | : Tyr131 | : Tyr123 |
124 | Gln121 | Gln132 | Gln124 |
164 | Trp154 | Trp165 | Trp157 |
165 | Leu155 | Leu166 | Leu158 |
216 | Lys205 | Lys216 | Lys208 |
217 | Thr206 | Thr217 | Thr209 |
218 | Gly207 | Gly218 | Gly210 |
219 | : PHE208 | : TRP219 | : TYR211 |
220 | Ser209 | : Ala220 | Ser212 |
221 | Gly210 | Met221 | Thr213 |
225 | Glu214 | Asp222 | Arg214 |
257 | Glu244 | . Glu253 | . Ser242 |
260 | Leu247 | Ala256 | Leu247 |
263 | Arg250 | Arg259 | Arg250 |
* Amino acids in bold are active site residues. Residues stabilizing the oxyanion cleft of the active region are capitalized, residues connecting the conserved active Ser and Lys residues are italicized, and carboxylated Lys residues are labeled with ‘CX’.